Literature DB >> 8047721

High-dose rate brachytherapy has a curative potential in patients with intraluminal squamous cell lung cancer.

G Sutedja1, G Baris, N van Zandwijk, P E Postmus.   

Abstract

Two patients presented with intraluminal T1N0 squamous cell lung cancer. Poor lung function precluded surgical resection and/or external radiotherapy. They were treated up to 3 times with high-dose rate brachytherapy (10 Gy at 1 cm each session) with curative intent. Follow-up has been 54 and 25 months. Brachytherapy is an effective and well-tolerated bronchoscopic treatment alternative with a curative potential in patients with small T1N0 intraluminal lung cancer.

Entities:  

Mesh:

Year:  1994        PMID: 8047721     DOI: 10.1159/000196330

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  4 in total

1.  High dose rate endobronchial brachytherapy for the treatment of lung cancer: current status and indications.

Authors:  P Barber; R Stout
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

Review 2.  HDR endobronchial brachytherapy in palliative and combined radical treatment of lung cancer.

Authors:  Jacek Fijuth
Journal:  J Contemp Brachytherapy       Date:  2010-01-13

Review 3.  Brachytherapy in the treatment of lung cancer - a valuable solution.

Authors:  Janusz Skowronek
Journal:  J Contemp Brachytherapy       Date:  2015-09-14

4.  Clinical and endoscopic response to high dose rate endobronchial brachytherapy in malignant lung tumors: A single centre experience.

Authors:  Sneha Dhillon; Saurabh Bansal; Girish Sindhwani; Meenu Gupta; Vipul Nautiyal; Sunil Saini; Mushtaq Ahmad
Journal:  South Asian J Cancer       Date:  2018 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.